tirzepatide non responders Doctor, I'm not losing weight on the GLP1” 🛑👇🏻 When When Weight-Loss Drugs Don't Work

Dual-Agonist Comparisons Tirzepatide (found in medications like Mounjaro) targets two receptors: GLP-1 and GIP

New clinical trial evidence suggests targeting both obesity and sleep-disordered breathing together may reshape cardiometabolic risk management in obstructive sleep apnea

particularly useful when preserving fertility is a priority

Of note, more than 50% of participants in the tirzepatide 10 and 15 mg groups experienced weight reductions of over 20%

A combination of ferroptosis inducers and HSF1 inhibitors resulted in tumor growth arrest in mice

must be submitted at least 48 hours before your renewal date Coverage: not currently available in Alabama, Arkansas, Louisiana, or Mississippi, per HumeCare's own disclosures What Is HumeCare+ and Who Is It For